Literature DB >> 29774452

Lymphedema following cancer therapy: overview and options.

Michael Bernas1, Saskia R J Thiadens2, Betty Smoot3, Jane M Armer4, Paula Stewart5,6, Jay Granzow7,8.   

Abstract

This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.

Entities:  

Keywords:  Advocacy; Diagnosis; Genetics; Imaging; Lymphedema; Treatment

Mesh:

Year:  2018        PMID: 29774452     DOI: 10.1007/s10585-018-9899-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  23 in total

1.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

Review 2.  A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011.

Authors:  Bonnie B Lasinski; Kathryn McKillip Thrift; Decourcy Squire; Melanie K Austin; Kandis M Smith; Ausanee Wanchai; Jason M Green; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  PM R       Date:  2012-08       Impact factor: 2.298

3.  MRI of lymphatic abnormalities after functional single-ventricle palliation surgery.

Authors:  Yoav Dori; Marc S Keller; Mark A Fogel; Jonathan J Rome; Kevin K Whitehead; Matthew A Harris; Maxim Itkin
Journal:  AJR Am J Roentgenol       Date:  2014-05-21       Impact factor: 3.959

4.  The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema.

Authors:  Takumi Yamamoto; Nana Matsuda; Kentaro Doi; Azusa Oshima; Hidehiko Yoshimatsu; Takeshi Todokoro; Fusa Ogata; Makoto Mihara; Mitsunaga Narushima; Takuya Iida; Isao Koshima
Journal:  Plast Reconstr Surg       Date:  2011-10       Impact factor: 4.730

5.  Putting evidence into practice: cancer-related lymphedema.

Authors:  Mei R Fu; Jie Deng; Jane M Armer
Journal:  Clin J Oncol Nurs       Date:  2014       Impact factor: 1.027

6.  Potassium Channel Candidate Genes Predict the Development of Secondary Lymphedema Following Breast Cancer Surgery.

Authors:  Betty Smoot; Kord M Kober; Steven M Paul; Jon D Levine; Gary Abrams; Judy Mastick; Kimberly Topp; Yvette P Conley; Christine A Miaskowski
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

7.  Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

Authors:  David N Finegold; Catherine J Baty; Kelly Z Knickelbein; Shelley Perschke; Sarah E Noon; Diana Campbell; Jenny M Karlsson; Diana Huang; Mark A Kimak; Elizabeth C Lawrence; Eleanor Feingold; Stephen D Meriney; Adam M Brufsky; Robert E Ferrell
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

Review 8.  Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.

Authors:  Janice N Cormier; Robert L Askew; Kristi S Mungovan; Yan Xing; Merrick I Ross; Jane M Armer
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

9.  The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2016-12       Impact factor: 1.286

Review 10.  Genetics of lymphatic anomalies.

Authors:  Pascal Brouillard; Laurence Boon; Miikka Vikkula
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

View more
  5 in total

Review 1.  Virtual Reality Rehabilitation Systems for Cancer Survivors: A Narrative Review of the Literature.

Authors:  Antonio Melillo; Andrea Chirico; Giuseppe De Pietro; Luigi Gallo; Giuseppe Caggianese; Daniela Barone; Michelino De Laurentiis; Antonio Giordano
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

Review 2.  Role of Transcriptional and Epigenetic Regulation in Lymphatic Endothelial Cell Development.

Authors:  Hyeonwoo La; Hyunjin Yoo; Young Bin Park; Nguyen Xuan Thang; Chanhyeok Park; Seonho Yoo; Hyeonji Lee; Youngsok Choi; Hyuk Song; Jeong Tae Do; Kwonho Hong
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

3.  Prevelance of upper extremity lymphedema and risk factors in patients with mastectomy: Single-center, observational, cross-sectional study.

Authors:  Tuba Tülay Koca; Gökmen Aktaş; Mehmet Emre Kurtgil
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

4.  Impact of body mass index on long-term surgical outcomes of vascularized lymph node transfer in lymphedema patients.

Authors:  Pedro Ciudad; Antonio J Forte; Maria T Huayllani; Daniel Boczar; Oscar J Manrique; Samyd S Bustos; Atenas Bustamante; Hung-Chi Chen
Journal:  Gland Surg       Date:  2020-04

Review 5.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.